Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lindsley

Showing results (301-310 of 570) with videos related to

Pageof 57
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 28, 2018
Muscarinic M<sub>5</sub> receptors modulate ethanol seeking in ratsAlice E Berizzi, Christina J Perry, David M Shackleford, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based leadCarrie K Jones, Douglas J Sheffler, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in ratsAndrew S Felts, Stacey R Lindsley, Jeffrey P Lamb, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channelsHaibo Yu, Zhihong Lin, Margrith E Mattmann, et al.
The Journal of Biological Chemistry|June 1, 2013
Regulation of phospholipase D activity and phosphatidic acid production after purinergic (P2Y6) receptor stimulationSarah A Scott, Yun Xiang, Thomas P Mathews, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 28, 2014
M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's locationDaniel J Foster, Patrick R Gentry, Jose E Lizardi-Ortiz, et al.
Journal of Medicinal Chemistry|January 20, 2017
Discovery of a Novel Series of Orally Bioavailable and CNS Penetrant Glucagon-like Peptide-1 Receptor (GLP-1R) Noncompetitive Antagonists Based on a 1,3-Disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione CoreKellie D Nance, Emily L Days, C David Weaver, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2016
Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compoundJeanette L Bertron, Elizabeth A Ennis, Christopher J Tarr, et al.
Science Signaling|December 5, 2019
Biased M<sub>1</sub> receptor-positive allosteric modulators reveal role of phospholipase D in M<sub>1</sub>-dependent rodent cortical plasticitySean P Moran, Zixiu Xiang, Catherine A Doyle, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu<sub>7</sub> Positive Allosteric Modulator Tool CompoundCarson W Reed, Jacob J Kalbfleisch, Madison J Wong, et al.
Pageof 57

Showing results (301-310 of 570) with videos related to

Sort By:
Pageof 57
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 28, 2018
Muscarinic M<sub>5</sub> receptors modulate ethanol seeking in ratsAlice E Berizzi, Christina J Perry, David M Shackleford, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based leadCarrie K Jones, Douglas J Sheffler, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in ratsAndrew S Felts, Stacey R Lindsley, Jeffrey P Lamb, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channelsHaibo Yu, Zhihong Lin, Margrith E Mattmann, et al.
The Journal of Biological Chemistry|June 1, 2013
Regulation of phospholipase D activity and phosphatidic acid production after purinergic (P2Y6) receptor stimulationSarah A Scott, Yun Xiang, Thomas P Mathews, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 28, 2014
M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's locationDaniel J Foster, Patrick R Gentry, Jose E Lizardi-Ortiz, et al.
Journal of Medicinal Chemistry|January 20, 2017
Discovery of a Novel Series of Orally Bioavailable and CNS Penetrant Glucagon-like Peptide-1 Receptor (GLP-1R) Noncompetitive Antagonists Based on a 1,3-Disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione CoreKellie D Nance, Emily L Days, C David Weaver, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2016
Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compoundJeanette L Bertron, Elizabeth A Ennis, Christopher J Tarr, et al.
Science Signaling|December 5, 2019
Biased M<sub>1</sub> receptor-positive allosteric modulators reveal role of phospholipase D in M<sub>1</sub>-dependent rodent cortical plasticitySean P Moran, Zixiu Xiang, Catherine A Doyle, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu<sub>7</sub> Positive Allosteric Modulator Tool CompoundCarson W Reed, Jacob J Kalbfleisch, Madison J Wong, et al.
Pageof 57